First Line Treatment of Metastatic Pancreatic Endocrine Carcinomas with Capecitabine and Temozolomide

被引：0
|
作者：
Strosberg, J. [1 ]
Choi, J. [1 ]
Gardner, N. [1 ]
Kvols, L. [1 ]
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
来源：
NEUROENDOCRINOLOGY | 2009年 / 90卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
93
引用
收藏
页码：136 / 136
页数：1
相关论文
共 50 条
  • [31] Capecitabine monotherapy in metastatic colorectal cancer - Effectiveness as first, second and third line treatment
    Schaberl-Moser, Renate
    Bauernhofer, Thomas
    Halm, Michael
    Pirchmoser, Renate
    Samonigg, Hellmut
    ANNALS OF ONCOLOGY, 2004, 15 : 95 - 95
  • [32] Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer
    Karacetin, D.
    Yalcin, B.
    Okten, B.
    Ozturk, S.
    Maral, O.
    Incekara, O.
    JOURNAL OF BUON, 2009, 14 (04): : 605 - 608
  • [33] Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
    J Feliu
    M J Safont
    A Salud
    F Losa
    C García-Girón
    C Bosch
    P Escudero
    R López
    C Madroñal
    M Bolaños
    M Gil
    A Llombart
    J Castro-Carpeño
    M González-Barón
    British Journal of Cancer, 2010, 102 : 1468 - 1473
  • [34] Capecitabine and oxaliplatin (XELOX) as first line treatment for patients with metastatic colorectal cancer (MCRC)
    Karacetin, D.
    Maral, O.
    Yalcyn, B.
    Okten, B.
    Incekara, O.
    ANNALS OF ONCOLOGY, 2006, 17 : 73 - 73
  • [35] Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
    Feliu, J.
    Safont, M. J.
    Salud, A.
    Losa, F.
    Garcia-Giron, C.
    Bosch, C.
    Escudero, P.
    Lopez, R.
    Madronal, C.
    Bolanos, M.
    Gil, M.
    Llombart, A.
    Castro-Carpeno, J.
    Gonzalez-Baron, M.
    BRITISH JOURNAL OF CANCER, 2010, 102 (10) : 1468 - 1473
  • [36] A phase II study of lapatinib and capecitabine in second-line treatment of metastatic pancreatic cancer
    Wu, Zheng
    Marshall, John
    Hwang, Jimmy J.
    Pishvaian, Michael J.
    Wellstein, Anton
    Weiner, Louis M.
    He, Aiwu Ruth
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [37] Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer
    Zheng Wu
    Andrew Gabrielson
    Jimmy J. Hwang
    Michael J. Pishvaian
    Louis M. Weiner
    Tingting Zhuang
    Lisa Ley
    John L. Marshall
    Aiwu Ruth He
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 1309 - 1314
  • [38] Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer
    Wu, Zheng
    Gabrielson, Andrew
    Hwang, Jimmy J.
    Pishvaian, Michael J.
    Weiner, Louis M.
    Zhuang, Tingting
    Ley, Lisa
    Marshall, John L.
    He, Aiwu Ruth
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (06) : 1309 - 1314
  • [39] Effectiveness and tolerability of maintenance capecitabine administrated to patients with metastatic pancreatic cancer treated with first line FOLFIRINOX
    Reure, Juliette
    Follana, Philippe
    Gal, Jocelyn
    Evesque, Ludovic
    Cavaglione, Gerard
    Saint, Angelique
    Francois, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [40] The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors
    Ramirez, Robert A.
    Beyer, David T.
    Chauhan, Aman
    Boudreaux, J. Philip
    Wang, Yi-Zarn
    Woltering, Eugene A.
    ONCOLOGIST, 2016, 21 (06): : 671 - 675
12345